About Provista Diagnostics
Provista Diagnostics is a company based in New York (United States) founded in 2007 was acquired by Todos Medical in January 2020.. Provista Diagnostics has raised $41.75 million across 13 funding rounds from investors including Todos Medical and Ascenda BioSciences. The company has 2 employees as of December 31, 2020. Provista Diagnostics has completed 1 acquisition, including RCP Diagnostics. Provista Diagnostics offers products and services including Live Draw SDY. Provista Diagnostics operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter New York, United States
- Employees 2 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Provista Diagnostics, Inc.
-
Annual Revenue
$00as on Aug 03, 2015
-
Net Profit
-
EBITDA
-
Total Equity Funding
$41.75 M (USD)
in 13 rounds
-
Latest Funding Round
-
Investors
Todos Medical
& 1 more
-
Employee Count
2
as on Dec 31, 2020
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Provista Diagnostics
Provista Diagnostics offers a comprehensive portfolio of products and services, including Live Draw SDY. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides real-time results and updates for Sydney lottery draws online
Unlock access to complete
Unlock access to complete
Funding Insights of Provista Diagnostics
Provista Diagnostics has successfully raised a total of $41.75M across 13 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Last Round
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Debt – Conventional - Provista Diagnostics | Valuation |
investors |
|
| May, 2018 | Amount | Series C - Provista Diagnostics | Valuation |
investors |
|
| Jul, 2017 | Amount | Series C - Provista Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Provista Diagnostics
Provista Diagnostics has secured backing from 2 investors. Prominent investors backing the company include Todos Medical and Ascenda BioSciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diagnostic services for microbe detection are provided using PCR-DNA technology.
|
Founded Year | Domain | Location | |
|
Todos Medical is focused on developing diagnostic blood tests.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Provista Diagnostics
Provista Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include RCP Diagnostics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Blood-based immunoassays for women's cancers were developed.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Provista Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Provista Diagnostics Comparisons
Competitors of Provista Diagnostics
Provista Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| domain | founded_year | HQ Location |
Diagnostic services are provided through laboratories and radiology units.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Provista Diagnostics
Frequently Asked Questions about Provista Diagnostics
When was Provista Diagnostics founded?
Provista Diagnostics was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Where is Provista Diagnostics located?
Provista Diagnostics is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Provista Diagnostics a funded company?
Provista Diagnostics is a funded company, having raised a total of $41.75M across 13 funding rounds to date. The company's 1st funding round was a Series C of $2.33M, raised on May 14, 2010.
How many employees does Provista Diagnostics have?
As of Dec 31, 2020, the latest employee count at Provista Diagnostics is 2.
What does Provista Diagnostics do?
Founded in 2007 and based in New York, United States, Provista Diagnostics operates in the molecular oncology sector. Blood-based tests are developed for early recognition of oncology-related diseases, with efforts centered on womens cancers including breast and ovarian types. Proprietary ProteoMark Technology is utilized, integrating serum protein biomarkers, tumor-associated autoantibodies, and patient clinical data to support accurate diagnosis.
Who are the top competitors of Provista Diagnostics?
Provista Diagnostics's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
What products or services does Provista Diagnostics offer?
Provista Diagnostics offers Live Draw SDY.
How many acquisitions has Provista Diagnostics made?
Provista Diagnostics has made 1 acquisition, including RCP Diagnostics.
Who are Provista Diagnostics's investors?
Provista Diagnostics has 2 investors. Key investors include Todos Medical, and Ascenda BioSciences.